Novo Nordisk
NVO
#108
Rank
โ‚น16.751 T
Marketcap
โ‚น3,798
Share price
2.20%
Change (1 day)
-14.37%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.141 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.22 Billion. In 2025 the company made an earning of โ‚น1.990 Trillion, an increase over its 2024 earnings that were of โ‚น1.872 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.141 T7.58%
2025 โ‚น1.990 T6.28%
2024 โ‚น1.872 T28.01%
2023 โ‚น1.462 T57.81%
2022 โ‚น927.00 B5.24%
2021 โ‚น880.88 B12.38%
2020 โ‚น783.82 B13.11%
2019 โ‚น692.98 B-3.45%
2018 โ‚น717.74 B1.88%
2017 โ‚น704.47 B4.3%
2016 โ‚น675.41 B10.32%
2015 โ‚น612.22 B7.47%
2014 โ‚น569.68 B3.4%
2013 โ‚น550.94 B19.09%
2012 โ‚น462.64 B15.58%
2011 โ‚น400.28 B16.58%
2010 โ‚น343.36 B25.66%
2009 โ‚น273.25 B10.68%
2008 โ‚น246.89 B55.82%
2007 โ‚น158.45 B7.02%
2006 โ‚น148.05 B19.05%
2005 โ‚น124.36 B10.55%
2004 โ‚น112.49 B
2002 โ‚น75.83 B-14.39%
2001 โ‚น88.57 B-52.82%
2000 โ‚น187.72 B250%
1999 โ‚น53.63 B31.21%
1998 โ‚น40.87 B34.31%
1997 โ‚น30.43 B11.46%
1996 โ‚น27.30 B9.03%
1995 โ‚น25.04 B-3.15%
1994 โ‚น25.85 B-0.67%
1993 โ‚น26.03 B45.38%
1992 โ‚น17.90 B-13.81%
1991 โ‚น20.77 B37.12%
1990 โ‚น15.14 B-0.79%
1989 โ‚น15.27 B26.2%
1988 โ‚น12.09 B24.97%
1987 โ‚น9.68 B-0.9%
1986 โ‚น9.77 B-7.78%
1985 โ‚น10.59 B24.87%
1984 โ‚น8.48 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น655.81 B-70.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.189 T 44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น679.86 B-69.16%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น1.130 T-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA